Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Soong

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Gynecologic Oncology|January 15, 2023
The role of adjuvant treatment for early-stage uterine clear cell carcinomasT J Orellana, A A Garrett, T R Soong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2015
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignanciesA L Wong, R A Soo, D S Tan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative StudyB Iacopetta, A Russo, V Bazan, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Gynecologic Oncology|January 15, 2023
The role of adjuvant treatment for early-stage uterine clear cell carcinomasT J Orellana, A A Garrett, T R Soong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2015
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignanciesA L Wong, R A Soo, D S Tan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative StudyB Iacopetta, A Russo, V Bazan, et al.
Pageof 5